InvestorsHub Logo
Followers 17
Posts 677
Boards Moderated 0
Alias Born 12/30/2004

Re: TheHungryHippo post# 11138

Thursday, 12/13/2018 12:56:04 PM

Thursday, December 13, 2018 12:56:04 PM

Post# of 27660
Anergis release:
http://www.anergis.ch/news/96-anergis-cop-2018-second-generation.html

EPALINGES, Switzerland, December 13th, 2018 – Anergis, a company developing proprietary ultra-fast Allergy Immunotherapy (AIT), announced today that the Company has successfully completed the mice proof-of-concept study of the second-generation COP allergy vaccines based on its research collaboration with Mymetics SA, a leader in the research and development of virosome-based vaccines. The Company plans to raise new financing to return to clinical trials in allergic patients as soon as possible.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News